What is the latest price of linezolid in 2024?

Linezolid (Linezolid) is a synthetic antibiotic belonging to the oxazolidinone class (Oxazolidinone). It is the first drug of this type of antibiotic to be clinically used. It was first approved by the U.S. Food and Drug Administration (FDA) in 2000 for the treatment of a variety of serious infections caused by Gram-positive bacteria.

Linezolid has now been launched in the domestic market and has been successfully included in the medical insurance system. Patients can easily purchase it domestically. For specific drug prices and medical insurance reimbursement details, please consult the pharmacy of your local hospital for accurate information. In addition, if you are looking for a more economical option, Indian generic drugs are a good consideration. The price of its 600mg*100 specification is only about more than 600 yuan, and its pharmaceutical ingredients are roughly the same as the domestic version.

Linezolid has a unique mechanism of action. It inhibits protein synthesis by binding to the 50S subunit of the bacterial ribosome, preventing the formation of the initiation complex. This mechanism is different from other common antibiotics, making linezolid excellent in fighting drug-resistant bacteria. In particular, linezolid has shown high efficacy against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Gram-positive strains that are resistant to a variety of other antibiotics.

In clinical applications, linezolid is mainly used to treat various complex infections, including hospital-acquired pneumonia, community-acquired pneumonia, complex skin and soft tissue infections, sepsis and other serious infections caused by drug-resistant Gram-positive bacteria. Due to its broad-spectrum antibacterial activity and good tissue penetration, linezolid provides an effective alternative when conventional antibiotic therapy is refractory.

Linezolid is usually administered orally or intravenously and is well absorbed with oral bioavailability approaching100% making it well suited for use in both outpatient and inpatient settings. Its broad tissue distribution and high lung penetration make it particularly effective in treating lung infections.